{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:30:29Z","timestamp":1793133029955,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.biopha.2017.01.164","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T00:02:24Z","timestamp":1487894544000},"page":"177-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["Pharmacodynamic study of eprosartan mesylate-loaded transfersomes Carbopol\u00ae gel under Dermaroller\u00ae on rats with methyl prednisolone acetate-induced hypertension"],"prefix":"10.1016","volume":"89","author":[{"given":"Abdul","family":"Ahad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmohsen A.","family":"Al-Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah M.","family":"Al-Mohizea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad I.","family":"Al-Jenoobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Raish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa Eldeen B.","family":"Yassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Aftab","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.01.164_bib0005","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jare.2016.07.003","article-title":"Improved bioavailability of timolol maleate via transdermal transfersomal gel: statistical optimization, characterization, and pharmacokinetic assessment","volume":"7","author":"Morsi","year":"2016","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.biopha.2017.01.164_bib0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ddtec.2005.05.003","article-title":"Vesicles as a tool for transdermal and dermal delivery","volume":"2","author":"Honeywell-Nguyen","year":"2005","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.biopha.2017.01.164_bib0015","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jsps.2013.12.019","article-title":"Systemic delivery of beta-blockers via transdermal route for hypertension","volume":"23","author":"Ahad","year":"2015","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.biopha.2017.01.164_bib0020","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1517\/17425247.2013.783562","article-title":"Transdermal delivery of calcium channel blockers for hypertension","volume":"10","author":"Ahad","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biopha.2017.01.164_bib0025","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3109\/10717544.2014.942444","article-title":"Transdermal delivery of angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACEIs) and others for management of hypertension","volume":"23","author":"Ahad","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2017.01.164_bib0030","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.drudis.2015.06.002","article-title":"Transdermal delivery of antidiabetic drugs: formulation and delivery strategies","volume":"20","author":"Ahad","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2017.01.164_bib0035","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1517\/13543770902989983","article-title":"Chemical penetration enhancers: a patent review","volume":"19","author":"Ahad","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.biopha.2017.01.164_bib0040","first-page":"276","article-title":"Transdermal drug delivery: the inherent challenges and technological advancements","volume":"5","author":"Ahad","year":"2010","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2017.01.164_bib0045","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3109\/03639045.2010.532219","article-title":"Role of novel terpenes in transcutaneous permeation of valsartan: effectiveness and mechanism of action","volume":"37","author":"Ahad","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.biopha.2017.01.164_bib0050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/156720111794479907","article-title":"Interactions between novel terpenes and main components of rat and human skin: mechanistic view for transdermal delivery of propranolol hydrochloride","volume":"8","author":"Ahad","year":"2011","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.biopha.2017.01.164_bib0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nano.2011.06.004","article-title":"Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan","volume":"8","author":"Ahad","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2017.01.164_bib0060","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/08982100902814006","article-title":"Phosphatidyl choline-based colloidal systems for dermal and transdermal drug delivery","volume":"19","author":"Ferderber","year":"2009","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.biopha.2017.01.164_bib0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jps.20737","article-title":"Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride","volume":"96","author":"Mishra","year":"2007","journal-title":"J. Pharm. Sci."},{"issue":"14 Suppl.","key":"10.1016\/j.biopha.2017.01.164_bib0070","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1038\/sj.jhh.1000991","article-title":"Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension","volume":"1","author":"Israili","year":"2000","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.biopha.2017.01.164_bib0075","first-page":"1921","article-title":"Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation","volume":"8","author":"Dai","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2017.01.164_bib0080","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijpharm.2014.06.041","article-title":"Nano-transfersomal ciprofloxacin-loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment","volume":"472","author":"Al-Mahallawi","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2017.01.164_bib0085","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.colsurfb.2008.12.030","article-title":"Development of different temoporfin-loaded invasomes-novel nanocarriers of temoporfin: characterization, stability and in vitro skin penetration studies","volume":"70","author":"Dragicevic-Curic","year":"2009","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2017.01.164_bib0090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijbiomac.2014.03.011","article-title":"Enhanced anti-inflammatory activity of carbopol-loaded meloxicam nanoethosomes gel","volume":"67","author":"Ahad","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2017.01.164_bib0095","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.colsurfb.2014.05.030","article-title":"Itraconazole-hydroxypropyl-beta-cyclodextrin-loaded deformable liposomes: in vitro skin penetration studies and antifungal efficacy using Candida albicans as model","volume":"121","author":"Alomrani","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2017.01.164_bib0100","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.2147\/IJN.S46748","article-title":"Enhanced transdermal bioavailability of testosterone propionate via surfactant-modified ethosomes","volume":"8","author":"Meng","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2017.01.164_bib0105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2174\/1573412911666150917195649","article-title":"Validation of a rapid and sensitive HPLC-UV method for the quantification of eprosartan mesylate in bulk drug, teventenTM and ultradeformable lipid based vesicular system","volume":"12","author":"Ahad","year":"2016","journal-title":"Curr. Pharm. Anal."},{"key":"10.1016\/j.biopha.2017.01.164_bib0110","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3109\/10717544.2014.902146","article-title":"Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study","volume":"22","author":"Khan","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2017.01.164_bib0115","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/08982104.2013.801489","article-title":"Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization","volume":"23","author":"Shamma","year":"2013","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.biopha.2017.01.164_bib0120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/2231-4040.97286","article-title":"Effect of permeation enhancers on the penetration mechanism of transfersomal gel of ketoconazole","volume":"3","author":"Rajan","year":"2012","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.biopha.2017.01.164_bib0125","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1517\/17425247.2014.914027","article-title":"Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats","volume":"11","author":"Ahad","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biopha.2017.01.164_bib0130","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijbiomac.2013.11.018","article-title":"Investigation of antihypertensive activity of carbopol valsartan transdermal gel containing 1,8-cineole","volume":"64C","author":"Ahad","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2017.01.164_bib0135","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jare.2016.03.003","article-title":"In vitro assessment of pharmaceutical potential of ethosomes entrapped with terbinafine hydrochloride","volume":"7","author":"Iizhar","year":"2016","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.biopha.2017.01.164_bib0140","doi-asserted-by":"crossref","first-page":"127495","DOI":"10.1155\/2014\/127495","article-title":"Evaluation of skin permeation and analgesic activity effects of carbopol lornoxicam topical gels containing penetration enhancer","volume":"2014","author":"Al-Suwayeh","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.biopha.2017.01.164_bib0145","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijbiomac.2013.11.018","article-title":"Investigation of antihypertensive activity of carbopol valsartan transdermal gel containing 1,8-cineole","volume":"64","author":"Ahad","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2017.01.164_bib0150","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1208\/s12249-015-0441-7","article-title":"Transfersomal nanoparticles for enhanced transdermal delivery of clindamycin","volume":"17","author":"Abdellatif","year":"2016","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.biopha.2017.01.164_bib0155","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4103\/0250-474X.106066","article-title":"Design and evaluation of microemulsion gel system of nadifloxacin","volume":"74","author":"Shinde","year":"2012","journal-title":"Indian. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2017.01.164_bib0160","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpharm.2010.06.034","article-title":"Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery","volume":"397","author":"El Zaafarany","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2017.01.164_bib0165","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5021\/ad.2013.25.1.46","article-title":"Safety evaluation of stamp type digital microneedle devices in hairless mice","volume":"25","author":"Park","year":"2013","journal-title":"Ann. Dermatol."},{"key":"10.1016\/j.biopha.2017.01.164_bib0170","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejps.2013.11.015","article-title":"Enhancing DNA delivery into the skin with a motorized microneedle device","volume":"52","author":"Yan","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2017.01.164_bib0175","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1023\/B:PHAM.0000029282.44140.2e","article-title":"Transdermal delivery of insulin using microneedles in vivo","volume":"21","author":"Martanto","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2017.01.164_bib0180","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11095-007-9350-0","article-title":"Characterization of solid maltose microneedles and their use for transdermal delivery","volume":"25","author":"Kolli","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2017.01.164_bib0185","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ejpb.2008.02.009","article-title":"Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein","volume":"69","author":"Oh","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2017.01.164_bib0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/10717540490265225","article-title":"Transdermal drug delivery systems of a beta blocker: design, in vitro, and in vivo characterization","volume":"11","author":"Aqil","year":"2004","journal-title":"Drug. Deliv."},{"key":"10.1016\/j.biopha.2017.01.164_bib0195","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/03639040903188471","article-title":"Pharmacodynamics of a losartan transdermal system for the treatment of hypertension","volume":"36","author":"Shams","year":"2010","journal-title":"Drug. Dev. Ind. Pharm."},{"key":"10.1016\/j.biopha.2017.01.164_bib0200","first-page":"1002","article-title":"Nano vesicular lipid carriers of angiotensin II receptor blocker: anti-hypertensive and skin toxicity study in focus","volume":"44","author":"Ahad","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.biopha.2017.01.164_bib0205","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1152\/ajplegacy.1975.228.2.613","article-title":"Effect of methylprednisolone upon arterial pressure and the renin angiotensin system in the rat","volume":"228","author":"Krakoff","year":"1975","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.biopha.2017.01.164_bib0210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/08982104.2012.753457","article-title":"Design and development of ethosomal transdermal drug delivery system of valsartan with preclinical assessment in Wistar albino rats","volume":"23","author":"Bhosale","year":"2013","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.biopha.2017.01.164_bib0215","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1208\/pt070106","article-title":"In vivo characterization of monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: a technical note","volume":"7","author":"Aqil","year":"2006","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.biopha.2017.01.164_bib0220","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/B978-0-12-420119-4.00019-7","article-title":"Western blotting using chemiluminescent substrates","volume":"541","author":"Alegria-Schaffer","year":"2014","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.biopha.2017.01.164_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-59745-542-8_1","article-title":"Origins of protein blotting","volume":"536","author":"Towbin","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2017.01.164_bib0230","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3565(25)08751-8","article-title":"Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes","volume":"82","author":"Draize","year":"1944","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2017.01.164_bib0235","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1016\/j.fct.2008.09.065","article-title":"In vivo evaluation of the safety of triptolide-loaded hydrogel-thickened microemulsion","volume":"46","author":"Xu","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2017.01.164_bib0240","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.jinorgbio.2005.07.017","article-title":"Safety and toxicological evaluation of a novel niacin-bound chromium (III) complex","volume":"99","author":"Shara","year":"2005","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biopha.2017.01.164_bib0245","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ejpb.2013.10.001","article-title":"Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin","volume":"86","author":"Liu","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2017.01.164_bib0250","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/j.2042-7158.2003.tb02748.x","article-title":"Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin","volume":"55","author":"Fang","year":"2003","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2017.01.164_bib0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2017.01.006","article-title":"Formulation and characterization of novel soft lipid-based nanoparticles for enhanced transdermal delivery of eprosartan mesylate","author":"Ahad","year":"2017","journal-title":"Saudi Pharm. J. (in press)"},{"key":"10.1016\/j.biopha.2017.01.164_bib0260","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.colsurfb.2013.09.045","article-title":"Carbopol gel containing chitosan-egg albumin nanoparticles for transdermal aceclofenac delivery","volume":"114","author":"Jana","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2017.01.164_bib0265","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ijbiomac.2013.09.049","article-title":"Topical gels of lidocaine HCl using cashew gum and Carbopol 940: preparation and in vitro skin permeation","volume":"62","author":"Das","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2017.01.164_bib0270","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijpharm.2007.03.052","article-title":"Hydrogel-thickened microemulsion for topical administration of drug molecule at an extremely low concentration","volume":"341","author":"Chen","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2017.01.164_bib0275","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpharm.2014.10.005","article-title":"Ropivacaine-loaded microemulsion and microemulsion-based gel for transdermal delivery: preparation, optimization, and evaluation","volume":"477","author":"Zhao","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2017.01.164_bib0280","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijpharm.2009.05.019","article-title":"Microemulsion-based hydrogel formulation of penciclovir for topical delivery","volume":"378","author":"Zhu","year":"2009","journal-title":"Int. J. Pharm."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216327950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216327950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:06:33Z","timestamp":1760094393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216327950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":56,"alternative-id":["S0753332216327950"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.01.164","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacodynamic study of eprosartan mesylate-loaded transfersomes Carbopol\u00ae gel under Dermaroller\u00ae on rats with methyl prednisolone acetate-induced hypertension","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.01.164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}